18508-92-4 Usage
Uses
Used in Organic Synthesis:
Trans-4-Methylcyclohexanol Methanesulfonate is used as a synthetic intermediate for the creation of various organic compounds. Its application in organic synthesis is due to its ability to facilitate the formation of new chemical bonds and structures, which can be further utilized in the development of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, trans-4-Methylcyclohexanol Methanesulfonate is used as a key building block for the synthesis of specific drug molecules. Its unique chemical properties allow for the creation of complex molecular structures that can target specific biological pathways, potentially leading to the development of novel therapeutic agents.
Used in Agrochemical Industry:
Trans-4-Methylcyclohexanol Methanesulfonate is also employed in the agrochemical industry for the synthesis of various agrochemical products, such as pesticides and herbicides. Its role in this industry is to contribute to the development of more effective and targeted chemical solutions for agricultural applications, ultimately aiming to improve crop yields and protect against pests.
Check Digit Verification of cas no
The CAS Registry Mumber 18508-92-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,5,0 and 8 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 18508-92:
(7*1)+(6*8)+(5*5)+(4*0)+(3*8)+(2*9)+(1*2)=124
124 % 10 = 4
So 18508-92-4 is a valid CAS Registry Number.
18508-92-4Relevant academic research and scientific papers
CYCLOPROPANECARBOXYLIC ACID DERIVATIVE
-
Paragraph 0326-0328, (2013/03/26)
A compound represented by the following general formula (I) or a pharmacologically acceptable salt thereof, wherein R1 represents a C1 to C6 alkyl group which may be substituted by one to three groups selected from substituent group A, or the like (substituent group A: a hydroxy group, a halogeno group, a cyano group, a nitro group, an amino group, a carboxy group, a C1 to C3 alkyl group, etc.); R2, R3, and R8 each independently represent a hydrogen atom or a C1 to C3 alkyl group; R4, R5, R6, R7, R9, and R10 each independently represent a hydrogen atom or the like; and R11 represents a hydrogen atom or the like, has TAFIa enzyme inhibitory activity and is useful as a therapeutic drug for myocardial infarction, angina pectoris, acute coronary syndrome, cerebral infarction, deep vein thrombosis, pulmonary embolism, or the like.
SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS
-
Page 104, (2010/02/06)
The present invention relates to CCR5 receptor antagonists of formulae (1a) or (1b), enantiomers, diastereomers, salts and solvates thereof wherein R1, R2, R3, R4, R5, and R7 are as defined herein. The invention further includes a method of CCR5-mediated
